Dr. Regina Berkovich discusses Mayzent, the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS).
Dr. Regina Berkovich is a neurologist with expertise in Multiple Sclerosis and other Demyelinating inflammatory conditions of the Central nervous system. She extensively published on the subject of MS and immunomodulatory therapies; her publications include classic papers on MS relapse diagnosis and therapy.
Her Ph.D. is in clinical pharmacology; a lot of her scientific work is dedicated to the mechanism of action of immunomodulatory medications. She served as a clinical, research and teaching faculty of the First Pavlov Medical University (St. Petersburg, Russia) and University of Southern California (Los Angeles, CA).
She was a Principal Investigator and CoInvestigator of several key clinical trials in Multiple Sclerosis. Currently, she directs a private Multiple Sclerosis Center in Beverly Hills and continues as a teaching faculty at USC.